You're here because you saw something real.
200 million Americans live with chronic inflammation. We're building the consumer health agent — and the brands — to actually help them. Here's the opportunity underneath that mission.
The shift
This isn't a someday future — it's already here. Clinically backed consumer brands for the inflammation generation.
Where most people are: managing it, not solving it.
Now within reach: less effort, better days.
The engine
We match biological signals with novel ingredients to scale consumer brands in weeks, not quarters — not months or years like legacy CPG.
A specific symptom → a precision strain + prebiotic formula → a consumer brand, shipped and scaling.
"We are an AI-native company. R3VY informs the engine. The engine executes research, formulation, creative, and channel ops as one system."
The window
+2,300% custom probiotic searches YoY. +340% gut-brain axis publications. $3B+ in recent CPG health acquisitions. Four tailwinds converging now.
The moat
Six proprietary assets, four exclusive partnerships. The moat isn't just the research — it's the distribution and execution.
The ask
Raising our seed: $1.0M round, $400K committed, $5.0M valuation cap, 20% discount. SAFE note.
Want the full investor summary?
We'll send the complete deck — market, traction, financials, and the ask.